Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhimin Shao

Showing results (41-50 of 203) with videos related to

Pageof 21
Sort By:
Journal of Translational Medicine|June 7, 2022
Integration of radiogenomic features for early prediction of pathological complete response in patients with triple-negative breast cancer and identification of potential therapeutic targetsYing Zhang, Chao You, Yuchen Pei, et al.
Breast Cancer (Tokyo, Japan)|February 17, 2018
Progression-free survival results in postmenopausal Asian women: subgroup analysis from a phase III randomized trial of fulvestrant 500 mg vs anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON)Shinzaburo Noguchi, Matthew J Ellis, John F R Robertson, et al.
Plos One|February 14, 2014
The role of mammographic calcification in the neoadjuvant therapy of breast cancer imaging evaluationJun-jie Li, Canming Chen, Yajia Gu, et al.
BMC Cancer|April 21, 2018
Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancerJia Jin, Yu Gao, Jian Zhang, et al.
Acta Biochimica Et Biophysica Sinica|January 1, 2010
c-myb activates CXCL12 transcription in T47D and MCF7 breast cancer cellsLi Chen, Siguang Xu, Xiaohua Zeng, et al.
Breast Cancer Research and Treatment|August 3, 2011
The role of topoisomerase IIα in predicting sensitivity to anthracyclines in breast cancer patients: a meta-analysis of published literaturesYueyao Du, Qiong Zhou, Wenjin Yin, et al.
The Oncologist|January 22, 2013
Radiotherapy can improve the disease-free survival rate in triple-negative breast cancer patients with T1-T2 disease and one to three positive lymph nodes after mastectomyXingxing Chen, Xiaoli Yu, Jiayi Chen, et al.
Medicine|December 15, 2015
Breast Sclerosing Adenosis and Accompanying Malignancies: A Clinicopathological and Imaging Study in a Chinese PopulationNaisi Huang, Jiajian Chen, Jingyan Xue, et al.
Breast (Edinburgh, Scotland)|April 16, 2022
Benefits of neoadjuvant therapy compared with adjuvant chemotherapy for the survival of patients with HER2-positive breast cancer: A retrospective cohort study at FUSCCShuyue Zheng, Lun Li, Ming Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|November 22, 2011
The efficacy of zoledronic acid in breast cancer adjuvant therapy: a meta-analysis of randomised controlled trialsTingting Yan, Wenjin Yin, Qiong Zhou, et al.
Pageof 21

Showing results (41-50 of 203) with videos related to

Sort By:
Pageof 21
Journal of Translational Medicine|June 7, 2022
Integration of radiogenomic features for early prediction of pathological complete response in patients with triple-negative breast cancer and identification of potential therapeutic targetsYing Zhang, Chao You, Yuchen Pei, et al.
Breast Cancer (Tokyo, Japan)|February 17, 2018
Progression-free survival results in postmenopausal Asian women: subgroup analysis from a phase III randomized trial of fulvestrant 500 mg vs anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON)Shinzaburo Noguchi, Matthew J Ellis, John F R Robertson, et al.
Plos One|February 14, 2014
The role of mammographic calcification in the neoadjuvant therapy of breast cancer imaging evaluationJun-jie Li, Canming Chen, Yajia Gu, et al.
BMC Cancer|April 21, 2018
Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancerJia Jin, Yu Gao, Jian Zhang, et al.
Acta Biochimica Et Biophysica Sinica|January 1, 2010
c-myb activates CXCL12 transcription in T47D and MCF7 breast cancer cellsLi Chen, Siguang Xu, Xiaohua Zeng, et al.
Breast Cancer Research and Treatment|August 3, 2011
The role of topoisomerase IIα in predicting sensitivity to anthracyclines in breast cancer patients: a meta-analysis of published literaturesYueyao Du, Qiong Zhou, Wenjin Yin, et al.
The Oncologist|January 22, 2013
Radiotherapy can improve the disease-free survival rate in triple-negative breast cancer patients with T1-T2 disease and one to three positive lymph nodes after mastectomyXingxing Chen, Xiaoli Yu, Jiayi Chen, et al.
Medicine|December 15, 2015
Breast Sclerosing Adenosis and Accompanying Malignancies: A Clinicopathological and Imaging Study in a Chinese PopulationNaisi Huang, Jiajian Chen, Jingyan Xue, et al.
Breast (Edinburgh, Scotland)|April 16, 2022
Benefits of neoadjuvant therapy compared with adjuvant chemotherapy for the survival of patients with HER2-positive breast cancer: A retrospective cohort study at FUSCCShuyue Zheng, Lun Li, Ming Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|November 22, 2011
The efficacy of zoledronic acid in breast cancer adjuvant therapy: a meta-analysis of randomised controlled trialsTingting Yan, Wenjin Yin, Qiong Zhou, et al.
Pageof 21